Elanco Animal Health Incorporated Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate
Elanco Animal Health Incorporated (ELAN) had Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate of 80.00% as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Debt
us-gaap:LongTermDebtPercentageBearingFixedInterestRate · last filed 2026-08-05
- 2026-06-30: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 80.00%.
- 2026-03-31: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 80.00%.
- 2025-12-31: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 80.00%.
- 2025-09-30: Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate 80.00%.
| Period end | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate |
|---|---|
| 2026-06-30 | 80.00% 10-Q · filed 2026-08-05 |
| 2026-03-31 | 80.00% 10-Q · filed 2026-05-06 |
| 2025-12-31 | 80.00% 10-K · filed 2026-02-24 |
| 2025-09-30 | 80.00% 10-Q · filed 2025-11-05 |
| 2025-06-30 | 89.00% 10-Q · filed 2025-08-07 |
| 2025-03-31 | 80.00% 10-Q · filed 2025-05-07 |
| 2024-12-31 | 82.00% 10-K · filed 2025-02-25 |
| 2024-09-30 | 81.00% 10-Q · filed 2024-11-07 |
| 2024-03-31 | 78.00% 10-Q · filed 2024-05-08 |
| 2023-12-31 | 78.00% 10-K · filed 2024-02-26 |
| 2023-09-30 | 76.00% 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |